Status:
UNKNOWN
Using Clinical Prediction Models to Improve Treatment for Patients With Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Providence Health & Services
Vancouver Coastal Health
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease of the lungs that affects more than 2.5 million Canadians. Patients with COPD experience episodes of lung attacks (or exacerbations). ...
Detailed Description
COPD is a heterogenous and progressive disease of the airways that affects millions of people worldwide. However, current treatment guidelines fail to provide personalised, patient-centered disease ma...
Eligibility Criteria
Inclusion
- Are a legal Canadian resident
- Aged 35 years and older
- Can speak English
- Have a diagnosis of COPD
Exclusion
- • Are under 35 years of age
Key Trial Info
Start Date :
March 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
1130 Patients enrolled
Trial Details
Trial ID
NCT05309356
Start Date
March 21 2023
End Date
July 1 2025
Last Update
May 10 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Lung Centre, Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9
2
St Paul's Hospital, Heart and Lung Centre
Vancouver, British Columbia, Canada, V6Z1Y6